Izrael - angielski - Ministry of Health

medison pharma ltd - carglumic acid - tablets dispersible - carglumic acid 200 mg - carglumic acid - carbaglu is indicated in treatment of :- hyperammonaemia due to n - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.

Kanada - angielski - Health Canada

recordati rare diseases - carglumic acid - tablet for suspension - 200mg - carglumic acid 200mg - ammonia detoxicants

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

orphan europe (uk - carglumic acid - dispersible tablet - 200mg

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

orpharma nz limited - carglumic acid 200mg - dispersible tablet - 200 mg - active: carglumic acid 200mg excipient: colloidal silicon dioxide crospovidone mannitol microcrystalline cellulose sodium stearyl fumarate - ucedane is indicated in treatment of hyperammonaemia due to nacetylglutamate synthase primary deficiency.

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

lucane pharma ltd - carglumic acid - dispersible tablet - 200mg

Arabia Saudyjska - angielski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

recordati rare diseases, france - carglumic acid - dispersible tablet - 200 mg,

Arabia Saudyjska - angielski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

recordati rare diseases, france - carglumic acid - dispersible tablet - 200 mg

Arabia Saudyjska - angielski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

recordati rare diseases, france - carglumic acid - dispersible tablet - 200 mg

Arabia Saudyjska - angielski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

jazeera pharmaceutical industries (jpi), saudi arabia - carglumic acid - dispersible tablet - 200 mg,

Japonia - angielski - すりの適正使用協議会 RAD-AR Council, Japan

recordati rare diseases japan k.k. - carglumic acid - white tablet, major axis: 18.0 mm, minor axis: 6.0 mm, thickness: 4.6 mm